| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.085 | 4.891 | 7.741 | 22.029 | 19.711 | 15.164 |
| Total Income - EUR | - | - | - | - | 4.085 | 4.891 | 7.741 | 22.029 | 19.711 | 15.164 |
| Total Expenses - EUR | - | - | - | - | 8 | 74 | 86 | 76 | 799 | 2.153 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.077 | 4.817 | 7.655 | 21.953 | 18.912 | 13.012 |
| Net Profit/Loss - EUR | - | - | - | - | 3.954 | 4.671 | 7.423 | 21.292 | 15.886 | 10.912 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cordisped Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 618 |
| Current Assets | - | - | - | - | 4.035 | 4.733 | 7.549 | 22.923 | 16.894 | 11.060 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 248 | 1.765 | 16.865 | 299 | 0 |
| Cash | - | - | - | - | 4.035 | 4.485 | 5.784 | 6.058 | 16.595 | 11.060 |
| Shareholders Funds | - | - | - | - | 3.997 | 4.726 | 7.496 | 22.727 | 16.104 | 11.246 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 38 | 7 | 53 | 196 | 790 | 432 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cordisped Medica S.r.l.